Find Ketazolam manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Canada

Canada

0

Australia

Australia

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Unakalm, Ansieten, Loftran, Anxon, 27223-35-4, Anseren
Molecular Formula
C20H17ClN2O3
Molecular Weight
368.8  g/mol
InChI Key
PWAJCNITSBZRBL-UHFFFAOYSA-N
FDA UNII
424J5HGB8E

Ketazolam
Ketazolam is a benzodiazepine derivative with anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant activity. Ketazolam is not approved in Canada or America.
1 2D Structure

Ketazolam

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
11-chloro-2,8-dimethyl-12b-phenyl-6H-[1,3]oxazino[3,2-d][1,4]benzodiazepine-4,7-dione
2.1.2 InChI
InChI=1S/C20H17ClN2O3/c1-13-10-18(24)23-12-19(25)22(2)17-9-8-15(21)11-16(17)20(23,26-13)14-6-4-3-5-7-14/h3-11H,12H2,1-2H3
2.1.3 InChI Key
PWAJCNITSBZRBL-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1=CC(=O)N2CC(=O)N(C3=C(C2(O1)C4=CC=CC=C4)C=C(C=C3)Cl)C
2.2 Other Identifiers
2.2.1 UNII
424J5HGB8E
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Marcen

2. Mi 49001

3. Sedotime

4. Solatran

5. U 28,774

6. Unakalm

2.3.2 Depositor-Supplied Synonyms

1. Unakalm

2. Ansieten

3. Loftran

4. Anxon

5. 27223-35-4

6. Anseren

7. U-28,774

8. (+)-ketazolam

9. (-)-ketazolam

10. Nsc 338158

11. U 28774

12. Ketazolam, (+)-

13. Ketazolam, (-)-

14. Nsc-338158

15. 424j5hgb8e

16. 92a214md7y

17. 9zbh5g9835

18. 11-chloro-2,8-dimethyl-12b-phenyl-6h-[1,3]oxazino[3,2-d][1,4]benzodiazepine-4,7-dione

19. U-28774

20. 11-chloro-8,12b-dihydro-2,8-dimethyl-12b-phenyl-4h-(1,3)oxazino(3,2-d)(1,4)benzodiazepine-4,7(6h)-dione

21. 4h-(1,3)oxazino(3,2-d)(1,4)benzodiazepine-4,7(6h)-dione, 11-chloro-8,12b-dihydro-2,8-dimethyl-12b-phenyl-

22. 4h-(1,3)oxazino(3,2-d)(1,4)benzodiazepine-4,7(6h)-dione, 8,12b-dihydro-11-chloro-2,8-dimethyl-12b-phenyl-

23. 4h-[1,3]oxazino[3,2-d][1,4]benzodiazepine-4,7(6h)-dione, 11-chloro-8,12b-dihydro-2,8-dimethyl-12b-phenyl-

24. Ketazolamum

25. Ketazolamum [inn-latin]

26. 106938-99-2

27. 106939-00-8

28. 4h-(1,3)oxazino(3,2-d)(1,4)benzodiazepine-4,7(6h)-dione, 11-chloro-8,12b-dihydro-2,8-dimethyl-12b-phenyl-, (+)-

29. 4h-(1,3)oxazino(3,2-d)(1,4)benzodiazepine-4,7(6h)-dione, 11-chloro-8,12b-dihydro-2,8-dimethyl-12b-phenyl-, (-)-

30. Einecs 248-346-3

31. Sedotime

32. Ketazolam [usan:inn:ban]

33. Unii-92a214md7y

34. Ketazolam [inn]

35. Ketazolam [mi]

36. Ketazolam (usan/inn)

37. Ketazolam [usan]

38. Ketazolam [mart.]

39. Ketazolam [who-dd]

40. (+/-)-ketazolam

41. Unii-424j5hgb8e

42. 11-chloro-8,12b-dihydro-2,8-dimethyl-12b-phenyl-4h-(1,3)-oxazino(3,2-d)(1,4)benzodiazepine-4,7(6h)dione

43. Schembl157329

44. Unii-9zbh5g9835

45. Chembl2104356

46. Dtxsid20865350

47. Chebi:135556

48. Hy-a0242

49. Nsc338158

50. Cs-6737

51. Db01587

52. 4h-(1,3)-oxazino(3,2-d)(1,4)benzodiazepine-4,7(6h)-dione, 11-chloro-8,12b-dihydro-2,8-dimethyl-

53. D04650

54. Q2397253

55. 4h-[1,2-d]-[1,4]benzodiazepine-4,7(6h)-dione, 11-chloro-8,12b-dihydro-2,8-dimethyl-

56. 11-chloro-2,8-dimethyl-12b-phenyl-8,12b-dihydro-4h-[1,3]oxazino[3,2-d][1,4]benzodiazepine-4,7(6h)-dione

57. 11-chloro-8,12b-dihydro-2,8-dimethyl-12b-phenyl-4h-(1,3)-oxazino(3,2-d)-(1,4)benzodiazepine-4,7(6h)dione

58. 11-chloro-8,12b-dihydro-2,8-dimethyl-12b-phenyl-4h-(1,3)-oxazino(3,2-d)[1,4]benzodiazepine-4,7(6h)-dione

59. 11-chloro-8,8-dimethyl-12b-phenyl-4h-[1,3]-oxazino[3,2-d]-[1,4]benzodiazepine-4,7(6h)dione

60. 14-chloro-4,10-dimethyl-2-phenyl-3-oxa-7,10-diazatricyclo[9.4.0.0^{2,7}]pentadeca-1(11),4,12,14-tetraene-6,9-dione

61. 4h-(1,3)-oxazino(3,2-d)-(1,4)benzodiazepine-4,7(6h)-dione, 11-chloro-8,12b-dihydro-2,8-dimethyl-

62. 4h-[1,2-d][1,4]benzodiazepine-4,7(6h)-dione, 11-chloro-8,12b-dihydro-2,8-dimethyl-12b-phenyl-

63. Ketazolam; 11-chloro-2,8-dimethyl-12b-phenyl-6h-[1,3]oxazino[3,2-d][1,4]benzodiazepine-4,7-quinone; 11-chloro-8,12b-dihydro-2,8-dimethyl-12b-phenyl-4h-(1,3)-oxazino(3,2-d)(1,4)benzodiazepine-4,7(6h)dione; 11-chloro-8,12b-dihydro-2,8-dimethyl-12b-phenyl-4h

2.4 Create Date
2005-03-26
3 Chemical and Physical Properties
Molecular Weight 368.8 g/mol
Molecular Formula C20H17ClN2O3
XLogP33
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count3
Rotatable Bond Count1
Exact Mass368.0927701 g/mol
Monoisotopic Mass368.0927701 g/mol
Topological Polar Surface Area49.8 Ų
Heavy Atom Count26
Formal Charge0
Complexity631
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Ketazolam could be used for the treatment of anxiety. In approved countries, it is indicated for the treatment of anxiety, tension, irritability and similar stress related symptoms.


5 Pharmacology and Biochemistry
5.1 Pharmacology

Benzodiazepines enhance the effect of the neurotransmitter gamma-aminobutyric acid (GABA), which results in sedative, hypnotic, anxiolytic, anticonvulsant, muscle relaxant and amnesic action. Benzodiazepines bind nonspecifically to benzodiazepine receptors which mediate sleep, affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABAA) receptors, this enhances the effects of GABA by increasing GABA affinity for the GABA receptor. Binding of GABA to the site opens the chloride channel, resulting in a hyperpolarized cell membrane that prevents further excitation of the cell.


5.2 MeSH Pharmacological Classification

Anti-Anxiety Agents

Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)


5.3 ATC Code

N - Nervous system

N05 - Psycholeptics

N05B - Anxiolytics

N05BA - Benzodiazepine derivatives

N05BA10 - Ketazolam


5.4 Absorption, Distribution and Excretion

Route of Elimination

Diazepam and its metabolites are excreted mainly in the urine, predominantly as their glucuronide conjugates.


5.5 Metabolism/Metabolites

Ketazolam is metabolized to diazepam, followed by demoxepam, and finally desmethyldiazepam.


5.6 Biological Half-Life

26-200 hours


5.7 Mechanism of Action

Benzodiazepines share a similar chemical structure and their effects in humans are mainly produced by the allosteric modification of a specific kind of neurotransmitter receptor, the GABAA receptor, which increases the conductance of this inhibitory channel; this results in the various therapeutic effects as well as adverse effects of benzodiazepines. Binding of benzodiazepines to this receptor complex promotes binding of GABA, which in turn increases the conduction of chloride ions across the neuronal cell membrane. This increased conductance raises the membrane potential of the neuron resulting in inhibition of neuronal firing. In addition, different GABAA receptor subtypes have varying distributions within different regions of the brain and therefore control distinct neuronal circuits. Hence, activation of different GABAA receptor subtypes by benzodiazepines may result in distinct pharmacological actions.


Global Sales Information

Do you need Business Intel? Ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty